These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 14617789

  • 1. Arsenic trioxide uses caspase-dependent and caspase-independent death pathways in myeloma cells.
    McCafferty-Grad J, Bahlis NJ, Krett N, Aguilar TM, Reis I, Lee KP, Boise LH.
    Mol Cancer Ther; 2003 Nov; 2(11):1155-64. PubMed ID: 14617789
    [Abstract] [Full Text] [Related]

  • 2. Arsenic trioxide selectively induces early and extensive apoptosis via the APO2/caspase-8 pathway engaging the mitochondrial pathway in myeloma cells with mutant p53.
    Akay C, Gazitt Y.
    Cell Cycle; 2003 Nov; 2(4):358-68. PubMed ID: 12851490
    [Abstract] [Full Text] [Related]

  • 3. Arsenic trioxide-induced apoptosis in myeloma cells: p53-dependent G1 or G2/M cell cycle arrest, activation of caspase-8 or caspase-9, and synergy with APO2/TRAIL.
    Liu Q, Hilsenbeck S, Gazitt Y.
    Blood; 2003 May 15; 101(10):4078-87. PubMed ID: 12531793
    [Abstract] [Full Text] [Related]

  • 4. Ascorbic acid enhances arsenic trioxide-induced cytotoxicity in multiple myeloma cells.
    Grad JM, Bahlis NJ, Reis I, Oshiro MM, Dalton WS, Boise LH.
    Blood; 2001 Aug 01; 98(3):805-13. PubMed ID: 11468182
    [Abstract] [Full Text] [Related]

  • 5. Arsenic trioxide induces apoptosis of myeloid leukemia cells by activation of caspases.
    Huang XJ, Wiernik PH, Klein RS, Gallagher RE.
    Med Oncol; 1999 Apr 01; 16(1):58-64. PubMed ID: 10382944
    [Abstract] [Full Text] [Related]

  • 6. Ethacrynic acid and a derivative enhance apoptosis in arsenic trioxide-treated myeloid leukemia and lymphoma cells: the role of glutathione S-transferase p1-1.
    Wang R, Liu C, Xia L, Zhao G, Gabrilove J, Waxman S, Jing Y.
    Clin Cancer Res; 2012 Dec 15; 18(24):6690-701. PubMed ID: 23082001
    [Abstract] [Full Text] [Related]

  • 7. The organic arsenic derivative GMZ27 induces PML-RARα-independent apoptosis in myeloid leukemia cells.
    Cheng X, Quintás-Cardama A, Golemovic M, Zingaro R, Gao MZ, Freireich EJ, Andreeff M, Kantarjian HM, Verstovsek S.
    Anticancer Res; 2012 Jul 15; 32(7):2871-80. PubMed ID: 22753750
    [Abstract] [Full Text] [Related]

  • 8. Arsenic trioxide induces accumulation of cytotoxic levels of ceramide in acute promyelocytic leukemia and adult T-cell leukemia/lymphoma cells through de novo ceramide synthesis and inhibition of glucosylceramide synthase activity.
    Dbaibo GS, Kfoury Y, Darwiche N, Panjarian S, Kozhaya L, Nasr R, Abdallah M, Hermine O, El-Sabban M, de Thé H, Bazarbachi A.
    Haematologica; 2007 Jun 15; 92(6):753-62. PubMed ID: 17550847
    [Abstract] [Full Text] [Related]

  • 9. TRAIL sensitisation by arsenic trioxide is caspase-8 dependent and involves modulation of death receptor components and Akt.
    Szegezdi E, Cahill S, Meyer M, O'Dwyer M, Samali A.
    Br J Cancer; 2006 Feb 13; 94(3):398-406. PubMed ID: 16434995
    [Abstract] [Full Text] [Related]

  • 10. Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia.
    Cai X, Shen YL, Zhu Q, Jia PM, Yu Y, Zhou L, Huang Y, Zhang JW, Xiong SM, Chen SJ, Wang ZY, Chen Z, Chen GQ.
    Leukemia; 2000 Feb 13; 14(2):262-70. PubMed ID: 10673743
    [Abstract] [Full Text] [Related]

  • 11. Suppression of arsenic trioxide-induced apoptosis in HeLa cells by N-acetylcysteine.
    Han YH, Kim SZ, Kim SH, Park WH.
    Mol Cells; 2008 Jul 31; 26(1):18-25. PubMed ID: 18511884
    [Abstract] [Full Text] [Related]

  • 12. Epoxyeicosatrienoic acids attenuate reactive oxygen species level, mitochondrial dysfunction, caspase activation, and apoptosis in carcinoma cells treated with arsenic trioxide.
    Liu L, Chen C, Gong W, Li Y, Edin ML, Zeldin DC, Wang DW.
    J Pharmacol Exp Ther; 2011 Nov 31; 339(2):451-63. PubMed ID: 21846841
    [Abstract] [Full Text] [Related]

  • 13. Involvement of CD95-independent caspase 8 activation in arsenic trioxide-induced apoptosis.
    Kitamura K, Minami Y, Yamamoto K, Akao Y, Kiyoi H, Saito H, Naoe T.
    Leukemia; 2000 Oct 31; 14(10):1743-50. PubMed ID: 11021749
    [Abstract] [Full Text] [Related]

  • 14. Arsenic-induced apoptosis in malignant cells in vitro.
    Akao Y, Yamada H, Nakagawa Y.
    Leuk Lymphoma; 2000 Mar 31; 37(1-2):53-63. PubMed ID: 10721769
    [Abstract] [Full Text] [Related]

  • 15. Arsenic trioxide mediates intrinsic and extrinsic pathways of apoptosis and cell cycle arrest in acute megakaryocytic leukemia.
    Lam HK, Li K, Chik KW, Yang M, Liu VC, Li CK, Fok TF, Ng PC, Shing MM, Chuen CK, Yuen PM.
    Int J Oncol; 2005 Aug 31; 27(2):537-45. PubMed ID: 16010437
    [Abstract] [Full Text] [Related]

  • 16. Arsenic trioxide inhibits the growth of Calu-6 cells via inducing a G2 arrest of the cell cycle and apoptosis accompanied with the depletion of GSH.
    Han YH, Kim SZ, Kim SH, Park WH.
    Cancer Lett; 2008 Oct 18; 270(1):40-55. PubMed ID: 18539383
    [Abstract] [Full Text] [Related]

  • 17. Arsenic trioxide promotes histone H3 phosphoacetylation at the chromatin of CASPASE-10 in acute promyelocytic leukemia cells.
    Li J, Chen P, Sinogeeva N, Gorospe M, Wersto RP, Chrest FJ, Barnes J, Liu Y.
    J Biol Chem; 2002 Dec 20; 277(51):49504-10. PubMed ID: 12388546
    [Abstract] [Full Text] [Related]

  • 18. Arsenic trioxide induces Noxa-dependent apoptosis in rhabdomyosarcoma cells and synergizes with antimicrotubule drugs.
    Meister MT, Boedicker C, Graab U, Hugle M, Hahn H, Klingebiel T, Fulda S.
    Cancer Lett; 2016 Oct 28; 381(2):287-95. PubMed ID: 27521572
    [Abstract] [Full Text] [Related]

  • 19. Molecular targets of arsenic trioxide in malignant cells.
    Miller WH.
    Oncologist; 2002 Oct 28; 7 Suppl 1():14-9. PubMed ID: 11961205
    [Abstract] [Full Text] [Related]

  • 20. CUDC-101 overcomes arsenic trioxide resistance via caspase-dependent promyelocytic leukemia-retinoic acid receptor alpha degradation in acute promyelocytic leukemia.
    Zhang T, Ma D, Wei D, Lu T, Yu K, Zhang Z, Wang W, Fang Q, Wang J.
    Anticancer Drugs; 2020 Feb 28; 31(2):158-168. PubMed ID: 31584454
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.